A venture firm warms to funding neuroscience – STAT
Longtime venture capital star Beth Seidenberg and former Amgen R&D chief Sean Harper say they are increasingly interested in funding neuroscience companies.
Related Articles
FDA approves schizophrenia drug that could alter how disorder is treated
The FDA has approved a new type of schizophrenia drug that may change the way the disorder is treated.
Scoop: VC titan Ben Horowitz dumps Trump, endorses Kamala Harris
He had previously endorsed Donald Trump
Scoop: VC titan Ben Horowitz dumps Trump, endorses Kamala Harris
He had previously endorsed Donald Trump
Q&A: AI is coming for lots of jobs. What about that of the cancer researcher?
Is Sam Altman right in suggesting an AI will replace the PI in cancer research? It comes down to the nature of creative thinking, says…
Trump backs off proposal to slash prescription drug prices by linking them to foreign countries
Trump is backing away from one of his biggest ideas to tackle the high cost of prescription drugs.
Trump backs off proposal to slash prescription drug prices by linking them to foreign countries
Trump is backing away from one of his biggest ideas to tackle the high cost of prescription drugs.
Was Missouri’s bird flu case a one-off or something more? Quest for answers faces testing delay
U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird flu passed the virus on…
Q&A: AI is coming for lots of jobs. What about that of the cancer researcher?
Is Sam Altman right in suggesting an AI will replace the PI in cancer research? It comes down to the nature of creative thinking, says…
What Kaiser Permanente learned from using Apple Watch tech in Parkinson’s care
Since late 2023, Kaiser has been giving some of its Parkinson’s patients an Apple Watch app called StrivePD, developed by Rune Labs.